Table 3. Biological Evaluation of Compounds against Bacterial and Intracellular Strains.
M. tuberculosis MIC (μg/mL) |
|||||
---|---|---|---|---|---|
CCM | CCM | ||||
Cmpd | H37Rva | 11.1a | 10.1a | GIC50 | SIb |
5a | 0.5–0.25 | 1 | 0.0025 | 23.4 | 47–94 |
5d | 0.06a-0.3c | 0.12 | <0.000625 | 11.7 | 195–39 |
5i | 0.25–0.12 | 0.5 | 0.00125 | 5.8 | 23–48 |
5l | 0.25–0.12 | 0.5 | <0.000625 | 3.9 | 16–32 |
INH | 0.24 | ||||
Rif | >0.06 |
M. tuberculosis clinical strains from Royal Free Hospital NHS Trust, London.
The selectivity index is calculated as the ratio of the GIC50 and the MIC observed against M. tuberculosis H37Rv.
MIC obtained from clinical strains from the Tuberculosis Research Laboratory, Sao Paulo.22